Powered by clinically-studied GLP-1promoting botanicals and prebiotic fibers, it helps extend satiety, steady cravings, and support a healthier metabolic and digestive rhythm throughout the day
BPC 157 and organ protection: Gut-brain-healing implications
Clinical Research Findings: SUSTAIN and PIONEER Trials A comprehensive safety analysis of 11,159 patients with type 2 diabetes across the SUSTAIN and PIONEER phase IIIa clinical trial programs found that gastrointestinal disorders occurred in 41.9% of patients receiving subcutaneous semaglutide and 39.1% receiving oral semaglutide, compared to 22.0% and 24.8% in comparator groups, respectively
Many insurance plans classify GLP-1 medications as specialty-tier drugs, which often require coinsurance payments rather than flat copays
"Many of the patients who quit their GLP-1 drugs could have stayed on them with the right personalized care." "Often, using a customized dosing plan helps the patient avoid undue side effects and helps them burn more fat, which is the mechanism by which GLP drugs work long-term and systemically," she told Fox News Digital
The short answer is yes, but the full picture is much more nuanced